Emerging problems in prion disease

CMAJ. Canadian Medical Association Journal

Volumn 155, Issue 5, 1996, Pages 549-551

  Dodelet, Vincent ^a   Ricketts, Maura ^b   Cashman, Neil R ^a  

^a MCGILL UNIVERSITY   (Canada)

^b LAB CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; BRAIN SPONGIOSIS; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; HUMAN; NONHUMAN; ORGAN TRANSPLANTATION; PRION DISEASE; RISK; SHORT SURVEY; UNITED KINGDOM;

EID: 0029817988     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (8)

1. Prusiner SB. Molecular biology of prion diseases. Science 1991;252:1515-22.
2. Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT, et al. Cell-free formation of protease-resistant prion protein. Nature 1994;370:471-4.
3. Hope J, Reekie LJ, Hunter N, Multhaup G, Beyreuther K, White H, et al. Fibrils from brains of cows with new cattle disease contain scrapie-associated protein. Nature 1988; 336:390-2.
4. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-5.
5. Lasmézas CI, Deslys JP, Demaimay R, Adjou KT, Lamoury F, Dormont D, et al. BSE transmission to macaques. Nature 1996;381:743-4.
6. Cashman NR, Loertscher R, Nalbantoglu J, Shaw I, Kascsak RJ, Bolton DC, et al. Cellular isoform of the scrapie agent protein participates in lymphocyte activation. Cell 1990; 61:185-92.
7. Brown P, Gajdusek DC, Gibbs CJ, et al. Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. N Engl J Med 1985;313:728-31.
8. Esmonde TFG, Will RG, Slattery JM. et al. Creutzfeldt-Jakob disease and blood transfusion. Lancet 1993; 341:205-7.